In recent years, the use of immune checkpoint inhibitors (ICIs) in combination with approved or experimental vaccines has proven to be a promising approach to improve vaccine …
Y Yao, J Li, K Qu, Y Wang, Z Wang, W Lu, Y Yu… - Cancer Immunology …, 2023 - Springer
Tumor immunotherapies have shown promising antitumor effects, especially immune checkpoint inhibitors (ICIs). However, only 12.46% of the patients benefit from the ICIs, the …
Since the discovery of lymphocytes with immunosuppressive activity, increasing interest has arisen in their possible influence on the immune response induced by vaccines. Regulatory …
M Zhu, S Wang, K Qu, F Lu, M Kou, Y Yao, T Zhu, Y Yu… - Iscience, 2024 - cell.com
The role of neutrophils in tumor initiation stage is rarely reported because of the lack of suitable models. We found that neutrophils recruited in early tumor nodules induced by …
The coronavirus pandemic has starkly demonstrated the need to create highly effective vaccines against various viral diseases. The emerging new platforms for vaccine creation …
VV Oberemok, OA Andreeva, EE Alieva - International Journal of …, 2023 - mdpi.com
The SARS-CoV-2 pandemic has demonstrated the need to create highly effective antivirals and vaccines against various RNA viruses, including SARS coronaviruses. This paper …
L Tu, Z Wang, L Yang, X Sun, Y Yao, P Zhang… - Frontiers in …, 2023 - frontiersin.org
Introduction Transforming growth factor β2 (TGF-β2), also known as glioma-derived T-cell suppressor factor, is associated with the impairment of tumor immune surveillance …